Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Neuroreport ; 22(3): 116-20, 2011 Feb 16.
Artigo em Inglês | MEDLINE | ID: mdl-21169872

RESUMO

Whether humans spontaneously sound out words in their mind during silent reading is a matter of debate. Some models of reading postulate that skilled readers access the meaning directly from print but others involve print-to-sound transcoding mechanisms. Here, we provide evidence that silent reading activates the sound form of words before accessing their meaning by comparing event-related potentials induced by highly expected words and their homophones. We found that expected words and words that sound the same but have a different orthography (homophones and pseudohomophones) reduce scalp activity to the same extent within 300 ms of presentation compared with unexpected words. This shows that phonological access during silent reading, which is critical for literacy acquisition, remains active in adulthood.


Assuntos
Córtex Cerebral/fisiologia , Potenciais Evocados/fisiologia , Reconhecimento Visual de Modelos/fisiologia , Fonética , Leitura , Comportamento Verbal/fisiologia , Adolescente , Feminino , Humanos , Testes de Linguagem/normas , Masculino , Estimulação Luminosa/métodos , Adulto Jovem
2.
Endocrinology ; 150(10): 4744-54, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19589868

RESUMO

Adequate fetal growth depends on placental transfer of nutrients and gases from the mother; thus, as pregnancy progresses, the placenta must grow to meet the increasing demands of the developing fetus. IGFs control proliferation, differentiation, and survival of trophoblast in first-trimester placenta via intracellular tyrosine kinase signaling cascades, the activation of which is also regulated by tyrosine phosphatases. The protein-tyrosine phosphatase, Src homology-2 domain containing protein tyrosine phosphatase (SHP)-2, is crucial for mouse placental development and is known to mediate IGF actions in other systems. In this study we examined the role of SHP-2 in regulating IGF-mediated proliferation in human trophoblast. Immunohistochemical analysis demonstrated that SHP-2 is expressed strongly in cytotrophoblast and only weakly in syncytium. After small interfering RNA-mediated knockdown of SHP-2 in BeWo choriocarcinoma cells and human first-trimester placental explants, IGF-induced trophoblast proliferation, examined using immunohistochemical analysis of Ki67 and 5-bromo-2'-deoxyuridine incorporation, was significantly reduced (P < 0.05). Kinase activation assays suggested that SHP-2 interacts with the MAPK pathway to mediate these effects. Markers of trophoblast differentiation were elevated after SHP-2 knockdown. This study demonstrates a role for tyrosine phosphatases in human trophoblast and establishes SHP-2 as a component of the IGF signaling pathway that is required for normal placental growth.


Assuntos
Proliferação de Células , Proteína Tirosina Fosfatase não Receptora Tipo 11/metabolismo , Somatomedinas/metabolismo , Trofoblastos/metabolismo , Linhagem Celular Tumoral , Feminino , Técnicas de Silenciamento de Genes , Humanos , Gravidez , Primeiro Trimestre da Gravidez , Proteínas Tirosina Fosfatases/metabolismo , RNA Interferente Pequeno/metabolismo , Transdução de Sinais
3.
J Neurosci ; 26(26): 6985-96, 2006 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-16807328

RESUMO

Accumulation of the microtubule-associated protein tau into neurofibrillary lesions is a pathological consequence of several neurodegenerative diseases, including Parkinson's disease and Alzheimer's disease. Hereditary mutations in the MAPT gene were shown to promote the formation of structurally distinct tau aggregates in patients that had a parkinsonian-like clinical presentation. Whether tau aggregates themselves or the soluble intermediate species that precede their aggregation are neurotoxic entities in these disorders has yet to be resolved; however, recent in vivo evidence supports the latter. We hypothesized that depletion of CHIP, a tau ubiquitin ligase, would lead to an increase in abnormal tau. Here, we show that deletion of CHIP in mice leads to the accumulation of non-aggregated, ubiquitin-negative, hyperphosphorylated tau species. CHIP-/- mice also have increased neuronal caspase-3 levels and activity, as well as caspase-cleaved tau immunoreactivity. Overexpression of mutant (P301L) human tau in CHIP-/- mice is insufficient to promote either argyrophilic or "pre-tangle" structures, despite marked phospho-tau accumulation throughout the brain. These observations are supported in post-developmental studies using RNA interference for CHIP (chn-1) in Caenorhabditis elegans and cell culture systems. Our results demonstrate that CHIP is a primary component in the ubiquitin-dependent degradation of tau. We also show that hyperphosphorylation and caspase-3 cleavage of tau both occur before aggregate formation. Based on these findings, we propose that polyubiquitination of tau by CHIP may facilitate the formation of insoluble filamentous tau lesions.


Assuntos
Encéfalo/metabolismo , Caspases/metabolismo , Deleção de Genes , Ubiquitina-Proteína Ligases/genética , Proteínas tau/metabolismo , Animais , Animais Geneticamente Modificados , Apoptose , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Caspase 3 , Linhagem Celular Tumoral , Ativação Enzimática , Proteínas de Choque Térmico HSP70/genética , Proteínas de Choque Térmico HSP70/metabolismo , Humanos , Camundongos , Camundongos Knockout , Camundongos Mutantes Neurológicos , Peso Molecular , Mutação , Proteínas do Tecido Nervoso/metabolismo , Neurônios/metabolismo , Fosforilação , Interferência de RNA , RNA Mensageiro/metabolismo , Estresse Fisiológico/metabolismo , Sinapses/metabolismo , Transcrição Gênica , Ubiquitina-Proteína Ligases/deficiência , Proteínas tau/química , Proteínas tau/genética
4.
Brain ; 129(Pt 4): 853-67, 2006 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-16401619

RESUMO

Over 30 different mutations have now been identified in MAPt that cause frontotemporal dementia (FTD). However, there are several families with FTD that show definite linkage to the region on chromosome 17 that contains MAPt, in which no mutation(s) has been identified. Although these families could have a complex mutation of the MAPt locus that has evaded detection it is also possible that another gene in this region is associated with FTD. This possibility is supported by neuropathological findings in these families, which consist of neuronal inclusions that are immunoreactive for ubiquitin (ub-ir) but not for tau. In addition to neuronal cytoplasmic inclusions, several chromosome 17-linked families are reported to have ub-ir neuronal intranuclear inclusions (NII); a finding which is uncommon in sporadic FTD. Here, we describe detailed clinical and neuropathological findings in a new large, multigenerational family with autosomal dominant FTD and autopsy proven tau-negative, ub-ir neuronal cytoplasmic and intranuclear inclusions. We have demonstrated that this family is linked to a 19.06 cM region of chromosome 17q21 with a maximum multipoint LOD score of 3.911 containing MAPt. By combining the results of our genetic analysis with those previously published for other families with similar pathology, we have further refined the minimal region to a 3.53 cM region of chromosome 17q21. We did not identify point mutations in MAPt by direct sequencing or any gross MAPt gene alterations using fluorescent in situ hybridization. In addition, tau protein extracted from members of this family was unremarkable in size and quantity as assessed by western blotting. Neuropathological characterization of the ub-ir NII in this family shows that they are positive for promyelocytic leukaemia protein (PML) and SUMO-1 that suggests that these inclusions form in the nuclear body and suggests a possible mechanism of neurodegeneration in tau-negative FTD linked to chromosome 17q21.


Assuntos
Cromossomos Humanos Par 17/genética , Demência/genética , Corpos de Inclusão Intranuclear/patologia , Idoso , Western Blotting , Demência/metabolismo , Demência/patologia , Feminino , Ligação Genética , Predisposição Genética para Doença , Humanos , Hibridização in Situ Fluorescente , Masculino , Pessoa de Meia-Idade , Neurônios/ultraestrutura , Linhagem , Ubiquitina/análise , Proteínas tau/análise , Proteínas tau/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA